Loading clinical trials...
Loading clinical trials...
Control-IQ 2.0 Feasibility Study #2: Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes
Conditions
Interventions
t:slim X2 insulin pump with Control-IQ technology 2.0
Locations
4
United States
Barbara Davis Center (Pediatric Clinic)
Aurora, Colorado, United States
Barbara Davis Center
Aurora, Colorado, United States
Joslin Diabetes Center
Boston, Massachusetts, United States
University of Virginia
Charlottesville, Virginia, United States
Start Date
February 1, 2023
Primary Completion Date
December 13, 2023
Completion Date
December 13, 2023
Last Updated
December 20, 2024
NCT07224321
NCT06815081
NCT07051005
NCT05188027
NCT07455994
NCT06575426
Lead Sponsor
Tandem Diabetes Care, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions